Pulmonx Corporation provided earnings guidance for the full year 2024. For the period, the company expects revenue for the full year 2023 to be in the range of $81 million to $84 million.
Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
8.755 USD | -0.28% | -6.55% | -31.69% |
May. 01 | Earnings Flash (LUNG) PULMONX CORPORATION Posts Q1 Revenue $18.9M, vs. Street Est of $17.9M | MT |
May. 01 | Transcript : Pulmonx Corporation, Q1 2024 Earnings Call, May 01, 2024 |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-31.69% | 341M | |
+75.41% | 12.38B | |
-20.57% | 7.76B | |
+6.33% | 6.61B | |
+12.78% | 5.4B | |
+38.73% | 4.96B | |
-17.43% | 4.75B | |
-24.72% | 3.89B | |
-29.51% | 2.66B | |
+51.37% | 2.45B |
- Stock Market
- Equities
- LUNG Stock
- News Pulmonx Corporation
- Pulmonx Corporation Provides Earnings Guidance for the Full Year 2024